Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1984 | 12-1983 | 12-1982 | 12-1981 | 12-1980 | |
| Sales | 2,712 | 943 | 1,069 | 1,233 | 751 |
| Cost of Goods | 179 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,200 | 943 | 1,069 | 1,233 | 751 |
| Operating Expenses | 5,928 | 4,201 | 2,473 | 1,742 | 1,465 |
| Operating Income | -3,217 | -3,258 | -1,404 | -509 | -713 |
| Interest Expense | 164 | 0 | 0 | 0 | 0 |
| Other Income | 923 | 4,523 | 1,419 | 1,263 | 504 |
| Pre-tax Income | -2,457 | 1,265 | 15 | 754 | -209 |
| Income Tax | -872 | 611 | -57 | 355 | -97 |
| Net Income Continuous | -1,718 | 654 | 72 | 399 | -112 |
| Net Income Discontinuous | 483 | 0 | 0 | 0 | 2,524 |
| Net Income | $-1,102 | $654 | $72 | $399 | $2,412 |
| EPS Basic Total Ops | -0.29 | 0.18 | 0.02 | 0.11 | N/A |
| EPS Basic Continuous Ops | -0.46 | 0.18 | 0.02 | 0.11 | N/A |
| EPS Basic Discontinuous Ops | 0.13 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.29 | 0.18 | 0.02 | 0.11 | N/A |
| EPS Diluted Continuous Ops | -0.46 | 0.18 | 0.02 | 0.11 | N/A |
| EPS Diluted Discontinuous Ops | 0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,217 | $-3,258 | $-1,404 | $-509 | $-713 |